Literature DB >> 7495518

Hepatitis C virus-specific T lymphocyte responses.

C M Rice1, C M Walker.   

Abstract

Hepatitis C virus establishes a persistent infection in humans and chimpanzees despite virus-specific cell-mediated immune responses. Available data suggest that these responses do provide some control of ongoing hepatitis C virus replication and are an important factor contributing to chronic hepatitis.

Entities:  

Mesh：

Year:  1995        PMID： 7495518     DOI： 10.1016/0952-7915(95)80099-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  13 in total

1.  Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Authors:  Mohamed Tarek Shata; Nancy Tricoche; Marion Perkus; Darley Tom; Betsy Brotman; Patricia McCormack; Wolfram Pfahler; Dong-Hun Lee; Leslie H Tobler; Michael Busch; Alfred M Prince
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

Review 2.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

4.  Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor.

Authors:  C M Chen; L R You; L H Hwang; Y H Lee
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.

Authors:  L R You; C M Chen; Y H Lee
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.

Authors:  P Cacoub; L Musset; P Hausfater; P Ghillani; F L Fabiani; F Charlotte; E Angevin; P Opolon; T Poynard; J C Piette; B Autran
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

8.  Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.

Authors:  A Bharat; F Barros; K Narayanan; B Borg; M Lisker-Melman; S Shenoy; J Lowell; J Crippin; W Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

9.  mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.

Authors:  S Shapiro; V Gershtein; N Elias; E Zuckerman; N Salman; N Lahat
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

10.  Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients.

Authors:  Fatima Esquivel; Agustín Albillos; Flavio Carrión; Alfredo Prieto; Eduardo Reyes; Belén Martínez-Martin; José Luis Calleja; Guillermo Cacho; Melchor Alvarez-Mon
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.